1. Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age
- Author
-
Henson, Katherine E., Reulen, Raoul C., Winter, David L., Bright, Chloe J., Fidler, Miranda M., Frobisher, Clare, Guha, Joyeeta, Wong, Kwok F., Kelly, Julie, Edgar, Angela B., McCabe, Martin G., Whelan, Jeremy, Cutter, David J., Darby, Sarah C., and Hawkins, Mike M.
- Subjects
Adult ,Male ,heart diseases ,Time Factors ,Adolescent ,neoplasms ,mortality ,Young Adult ,Risk Factors ,Original Research Articles ,cardiac deaths ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,Humans ,epidemiology ,Female ,Survivors - Abstract
Supplemental Digital Content is available in the text., Background: Survivors of teenage and young adult cancer are acknowledged as understudied. Little is known about their long-term adverse health risks, particularly of cardiac disease that is increased in other cancer populations where cardiotoxic treatments have been used. Methods: The Teenage and Young Adult Cancer Survivor Study cohort comprises 200 945 5-year survivors of cancer diagnosed at 15 to 39 years of age in England and Wales from 1971 to 2006, and followed to 2014. Standardized mortality ratios, absolute excess risks, and cumulative risks were calculated. Results: Two thousand sixteen survivors died of cardiac disease. For all cancers combined, the standardized mortality ratios for all cardiac diseases combined was greatest for individuals diagnosed at 15 to 19 years of age (4.2; 95% confidence interval, 3.4–5.2) decreasing to 1.2 (95% confidence interval, 1.1–1.3) for individuals aged 35 to 39 years (2P for trend
- Published
- 2016